Written by Psychedelic Alpha’s Noah Smith with support from Editor-at-Large and patent attorney Graham Pechenik of Calyx Law.

The Psychedelic Patent Update provides headline figures and data regarding published psychedelic patent applications and grants.

Overview

We added 4 PCTs and 18 U.S. patent applications focused on psychedelics to our tracer in September 2025. New entries came from the likes of Enveric Biosciences, Betterlife Therapeutics, Kuleon, atai Life Sciences, Clexio Biosciences, and more.

In November 2023, we also began regularly tracking prosecution status updates for the 1,300+ US patent applications in our database. As a result, we are now able to provide you with a more granular look at the psychedelic intellectual property landscape as it evolves in the US.

Using the interface below, you can explore applications that were not only published or granted in these months, but also those that were allowed, abandoned, rejected, or even instances where applicants filed responses to final and non-final rejections from Examiners. To access the underlying data, click the arrow in the top right corner of each box...